Galafold (migalastat)

pCPA File Number: 21024

Negotiation Status:

Concluded with an LOI

Indication(s):

Fabry Disease

Sponsor/Manufacturer:

Amicus Therapeutics

CDA-AMC Project Number:

SR0522-000

pCPA Engagement Letter Issued:

2018-03-28

Negotiation Process Concluded:

2018-08-28